Interactive Intelligence 10-Q 11 May 15 2015 Q1 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	3 Months Ended
	Mar. 31, 2015	Apr. 30, 2015
Document and Entity Information [Abstract]
Entity Registrant Name	Interactive Intelligence Group, Inc.
Entity Central Index Key	1517650
Current Fiscal Year End Date	-19
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		21,546,272
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q1
Document Type	10-Q
Amendment Flag	FALSE
Document Period End Date	31-Mar-15

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified
Current assets:
Cash and cash equivalents	$54,277	$36,168
Short-term investments	6,169	20,041
Accounts receivable, net of allowance for doubtful accounts of $900 at March 31, 2015 and $1,052 at December 31, 2014	74,988	87,413
Prepaid expenses	29,295	29,417
Other current assets	15,706	14,655
Total current assets	180,435	187,694
Long-term investments	4,497	5,495
Property and equipment, net	45,755	44,785
Capitalized software, net	39,344	33,598
Goodwill	42,429	43,732
Intangible assets, net	15,615	16,517
Other assets, net	6,741	6,902
Total assets	334,816	338,723
Current liabilities:
Accounts payable	10,435	10,236
Accrued liabilities	15,843	18,299
Accrued compensation and related expenses	17,078	19,211
Deferred license and hardware revenues	6,252	5,945
Deferred recurring revenues	75,584	76,647
Deferred services revenues	9,469	9,925
Total current liabilities	134,661	140,263
Long-term deferred revenues	20,327	18,158
Deferred tax liabilities, net	2,277	2,437
Other long-term liabilities	7,760	7,135
Total liabilities	165,025	167,993
Shareholders' equity:
Common stock, $0.01 par value; 100,000,000 authorized; 21,533,057 issued and outstanding at March 31, 2015, 21,278,858 issued and outstanding at December 31, 2014	215	213
Additional paid-in capital	202,412	196,691
Accumulated other comprehensive loss, net of tax	-8,764	-5,561
Accumulated Deficit	-24,072	-20,613
Total shareholders' equity	169,791	170,730
Total liabilities and shareholders' equity	$334,816	$338,723

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets (Parenthetical) (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, except Share data, unless otherwise specified
Current assets:
Accounts receivable, allowance for doubtful accounts	$900	$1,052
Shareholders' equity:
Common stock, par value (in dollars per share)	$0.01	$0.01
Common stock, shares authorized (in shares)	100,000,000	100,000,000
Common stock, shares issued (in shares)	21,533,057	21,278,858
Common stock , shares outstanding (in shares)	21,533,057	21,278,858

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Operations (USD $)	3 Months Ended
In Thousands, except Share data, unless otherwise specified	Mar. 31, 2015		Mar. 31, 2014
Revenues:
Recurring	$54,212		$43,409
License and hardware	21,621		22,846
Services	13,642		13,193
Total revenues	89,475		79,448
Costs of revenues:
Costs of recurring	18,744	[1],[2]	14,058	[1],[2]
Costs of premise licenses and hardware	6,529	[1],[2]	6,833	[1],[2]
Costs of services	11,251	[1],[2]	10,517	[1],[2]
Total costs of revenues	36,524	[1],[2]	31,408	[1],[2]
Gross profit	52,951		48,040
Operating expenses:
Sales and marketing	31,109	[1],[2]	28,155	[1],[2]
Research and development	13,837	[1],[2]	13,799	[1],[2]
General and administrative	12,776	[1],[2]	10,899	[1],[2]
Total operating expenses	57,722	[1],[2]	52,853	[1],[2]
Operating loss	-4,771		-4,813
Other income (expense):
Interest income, net	148		282
Other expense	-327		-196
Total other income (expense)	-179		86
Loss before income taxes	-4,950		-4,727
Income tax benefit	1,491		2,163
Net loss	($3,459)		($2,564)
Net loss per share:
Basic	($0.16)		($0.12)
Diluted	($0.16)		($0.12)
Shares used to compute net loss per share:
Basic	21,447		20,689
Diluted	21,447		20,689
[1]	Amounts include amortization of purchased intangibles from: Costs of license and hardware$ 177$ 49 General and administrative 449 472 Total intangible amortization expense$ 626$ 521
[2]	Amounts include stock-based compensation expense, as follows: Costs of recurring revenues$ 454$ 307 Costs of services revenues 129 106 Sales and marketing 561 1,096 Research and development 819 954 General and administrative 1,030 777 Total stock-based compensation expense$ 2,993$ 3,240

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements of Operations (Parenthetical) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Amounts include amortization of purchased intangibles
Total intangible amortization expense	$626	$521
Amounts include stock-based compensation expense
Total stock-based compensation expense	2,993	3,240
Costs Of License And Hardware [Member]
Amounts include amortization of purchased intangibles
Total intangible amortization expense	177	49
Costs Of Recurring Revenues [Member]
Amounts include stock-based compensation expense
Total stock-based compensation expense	454	307
Costs of Services Revenues [Member]
Amounts include stock-based compensation expense
Total stock-based compensation expense	129	106
Sales and Marketing [Member]
Amounts include stock-based compensation expense
Total stock-based compensation expense	561	1,096
Research and Development [Member]
Amounts include stock-based compensation expense
Total stock-based compensation expense	819	954
General and Administrative [Member]
Amounts include amortization of purchased intangibles
Total intangible amortization expense	449	472
Amounts include stock-based compensation expense
Total stock-based compensation expense	$1,030	$777

Condensed_Consolidated_Stateme2

Condensed Consolidated Statements of Comprehensive Loss (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Consolidated Statements of Comprehensive Loss [Abstract]
Net loss	($3,459)	($2,564)
Other comprehensive loss:
Foreign currency translation adjustment	-3,262	559
Net unrealized investment gain (loss) - net of tax	59	-17
Comprehensive loss	($6,662)	($2,022)

Condensed_Consolidated_Stateme3

Condensed Consolidated Statement of Shareholders' Equity (USD $)	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Comprehensive Loss [Member]	Accumulated Deficit [Member]	Total
In Thousands, except Share data
Balance at Dec. 31, 2014	$213	$196,691	($5,561)	($20,613)	$170,730
Balance (in shares) at Dec. 31, 2014	21,279,000				21,278,858
Stock-based compensation expense		3,621			3,621
Exercise of stock options	2	1,495			1,497
Exercise of stock options (in shares)	80,000
Issuances of common stock		388			388
Issuances of common stock (in shares)	9,000
Issuance of restricted stock units, net of tax		-2,306			-2,306
Issuance of restricted stock units, net of tax (in shares)	105,000
Issuance of retirement plan shares		2,523			2,523
Issuance of retirement plan shares (in shares)	60,000
Net loss				-3,459	-3,459
Foreign currency translation adjustment			-3,262		-3,262
Net unrealized investment loss			59		59
Balance at Mar. 31, 2015	$215	$202,412	($8,764)	($24,072)	$169,791
Balance (in shares) at Mar. 31, 2015	21,533,000				21,533,057

Condensed_Consolidated_Stateme4

Condensed Consolidated Statements of Cash Flows (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Operating activities:
Net loss	($3,459)	($2,564)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation	4,736	3,402
Amortization	626	521
Other non-cash items	-1,352	-96
Stock-based compensation expense	2,993	3,240
Excess tax benefit from stock-based payment arrangements		-814
Deferred income taxes	-160	-2,194
Amortization (accretion) of investment premium (discount)	124	-289
Loss on disposal of fixed assets	5	29
Changes in operating assets and liabilities:
Accounts receivable	12,425	9,655
Prepaid expenses	122	-5,680
Other current assets	-1,051	554
Accounts payable	199	2,444
Accrued liabilities	-1,483	2,309
Accrued compensation and related expenses	-2,133	-4,185
Deferred license and hardware revenues	2,174	564
Deferred recurring revenues	-1,199	-883
Deferred services revenues	-18	-119
Other assets and liabilities	785	-610
Net cash provided by operating activities	13,334	5,284
Investing activities:
Sales of available-for-sale investments	14,805	14,385
Purchases of available-for-sale investments		-25,135
Purchases of property and equipment	-6,260	-8,144
Capitalized internal use software cost	-5,872	-2,466
Unrealized loss on investment		15
Net cash provided by (used in) investing activities	2,673	-21,345
Financing activities:
Proceeds from stock options exercised	1,497	3,701
Proceeds from issuance of common stock	388	269
Tax withholding on restricted stock awards	-2,306	-2,614
Issuance of retirement plan shares	2,523
Excess tax benefit from stock-based payment arrangements		814
Net cash provided by financing activities	2,102	2,170
Net increase (decrease) in cash and cash equivalents	18,109	-13,891
Cash and cash equivalents, beginning of period	36,168	65,881
Cash and cash equivalents, end of period	54,277	51,990
Cash paid during the period for:
Interest		7
Income taxes	120	363
Other non-cash item:
Purchase of property and equipment payable at end of period	$746	$640

Financial_Statement_Presentati

Financial Statement Presentation	3 Months Ended
	Mar. 31, 2015
Financial Statement Presentation [Abstract]
Financial Statement Presentation
	1.FINANCIAL STATEMENT PRESENTATION
	The accompanying unaudited condensed consolidated financial statements of Interactive Intelligence Group, Inc. (“the Company,” “we,” “us” and “our”) have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and with the instructions for Form 10-Q and Article 10 of Regulation S-X for interim financial information. Accordingly, certain information and note disclosures normally included in the Company’s financial statements prepared in accordance with GAAP have been condensed, or omitted, pursuant to the rules and regulations of the United States Securities and Exchange Commission (the “SEC”).
	The preparation of the Company’s condensed consolidated financial statements requires management to make estimates and assumptions that affect reported amounts of assets and liabilities, at the respective balance sheet dates, and the reported amounts of revenues and expenses during the respective reporting periods. Despite management’s best effort to establish good faith estimates and assumptions, actual results could differ from these estimates. In management’s opinion, the Company’s accompanying condensed consolidated financial statements include all adjustments necessary (which are of a normal and recurring nature, except as otherwise noted) for the fair presentation of the results of the interim periods presented.
	The Company’s accompanying condensed consolidated financial statements as of December 31, 2014 have been derived from the Company’s audited consolidated financial statements at that date but do not include all of the information and notes required by GAAP for complete financial statements. These accompanying condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements for the year ended December 31, 2014, included in the Company’s most recent Annual Report on Form 10-K as filed with the SEC on February 27, 2015. The Company’s results of operations for any interim period are not necessarily indicative of the results of operations for any other interim period or for a full fiscal year.
	Principles of Consolidation
	The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries after elimination of all significant intercompany accounts and transactions.
	Revisions and Adjustments
	During the third quarter of 2014, the Company revised certain personnel related expenses which were included in cost of recurring revenues in prior periods to sales and marketing expenses. For the three months ended March 31, 2014, $700,000 has been revised to sales and marketing expenses based on this new expense presentation. The revision did not have any impact on the overall results previously reported.

Summary_Of_Certain_Accounting_

Summary Of Certain Accounting Policies And Recent Accounting Pronouncements	3 Months Ended
	Mar. 31, 2015
Summary Of Certain Accounting Policies And Recent Accounting Pronouncements [Abstract]
Summary Of Certain Accounting Policies And Recent Accounting Pronouncements
	2.SUMMARY OF CERTAIN ACCOUNTING POLICIES AND RECENT ACCOUNTING PRONOUNCEMENTS
	For a complete summary of the Company’s significant accounting policies and critical accounting estimates, refer to Note 2 of Notes to Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2014.
	In May 2014, the Financial Accounting Standards Board (“FASB”) issued FASB Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (“FASB ASU 2014-09”), which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. FASB ASU 2014-09 will replace most existing U.S. GAAP revenue recognition guidance when it becomes effective. As already issued, the new standard is effective for the Company on January 1, 2017, and early adoption is not permitted. In April 2015, the FASB voted to propose a one-year deferral of the effective date of the new revenue recognition standard. If the deferral is approved, the new standard will become effective for the Company beginning with the first quarter of 2018. This guidance permits the use of either the retrospective or cumulative effect transition method. The Company is evaluating the effect that FASB ASU 2014-09 will have on its consolidated financial statements and related disclosures. The Company has not yet selected a transition method nor has it determined the effect of the guidance on its ongoing financial reporting.
	The Company capitalizes costs related to its PureCloud PlatformSM and certain projects described below for internal use in accordance with FASB Accounting Standards Codification (“ASC”) 350-40, Internal Use Software. Once a solution has reached the development stage, internal and external costs, if direct and incremental, are capitalized until the software is substantially complete and ready for its intended use. The capitalization of costs ceases upon completion of all substantial testing. Costs incurred in the preliminary stages of development, maintenance and training costs are expensed as incurred. During the three months ended March 31, 2015 and 2014, the Company capitalized $5.6 million and $1.8 million, respectively, of costs related to the development of its PureCloud Platform. The Company began amortizing the development costs related to PureCloud CollaborateSM during the first quarter of 2015. The Company will continue to capitalize development costs related to other services provided under the PureCloud Platform and will begin amortizing such costs once those services are released for general availability.
	Additionally, the Company is implementing new business systems to meet its internal business needs. The Company has no plans to market such software externally. During the three months ended March 31, 2015 and 2014, the Company capitalized $0.9 million and $0.6 million, respectively, of costs associated with development and implementation of these systems.
	During the three months ended March 31, 2015, there were no other material changes to the Company’s significant accounting policies or critical accounting estimates.

Net_Income_Loss_Per_Share

Net Income (Loss) Per Share	3 Months Ended
	Mar. 31, 2015
Net Income (Loss) Per Share [Abstract]
Net Income (Loss) Per Share	3.NET LOSS PER SHARE
	Basic net loss per share is calculated based on the weighted-average number of common shares outstanding in accordance with FASB ASC Topic 260, Earnings per Share. Diluted net income per share is calculated based on the weighted-average number of common shares outstanding plus the effect of dilutive potential common shares. When the Company reports a net loss, the calculation of diluted net loss per share excludes potential common shares as the effect would be anti-dilutive. Potential common shares consist of shares of common stock issuable upon the exercise of stock options and vesting of restricted stock units (“RSUs”). The calculation of diluted net loss per share excludes shares underlying stock options outstanding that would be anti-dilutive. The following table sets forth the calculation of basic and diluted net loss per share (in thousands, except per share amounts):
		Three Months Ended March 31,
		2015		2014
	Net loss, as reported (A)	$	-3,459	$	-2,564
	Weighted average shares of common stock outstanding (B)		21,447		20,689
	Dilutive effect of employee stock options and RSUs		-		-
	Common stock and common stock equivalents (C)		21,447		20,689
	Net loss per share:
	Basic (A/B)	$	-0.16	$	-0.12
	Diluted (A/C)		-0.16		-0.12
	The Company’s calculation of diluted net loss per share for the three months ended March 31, 2015 and 2014 excludes RSUs and stock options to purchase approximately 374,000 and 214,000 shares of the Company’s common stock, respectively.

Investments

Investments	3 Months Ended
	Mar. 31, 2015
Investments [Abstract]
Investments	4.INVESTMENTS
	FASB ASC Topic 820, Fair Value Measurement (“FASB ASC 820”), as amended, defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. FASB ASC 820 also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes the following three levels of inputs that may be used to measure fair value:
		·		Level 1 - Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.
		·		Level 2 - Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
		·		Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
	The Company’s short-term investments all mature in less than one year and its long-term investments all mature within three years. Both short-term and long-term investments are considered available for sale. The Company’s assets that are measured at fair value on a recurring basis are classified within Level 1 or Level 2 of the fair value hierarchy. The types of instruments valued based on quoted market prices in active markets include money market securities and U.S government securities. Such instruments are classified within Level 1 of the fair value hierarchy. The Company invests in money market funds that are traded daily and does not adjust the quoted price for such instruments. The types of instruments valued based on quoted prices in less active markets, broker or dealer quotations, or alternative pricing sources with reasonable levels of price transparency include corporate notes, agency bonds, commercial paper and certificates of deposit. Such instruments are classified within Level 2 of the fair value hierarchy. The Company uses consensus pricing, which is based on multiple pricing sources, to value its fixed income investments.
	The following table sets forth a summary of the Company’s financial assets, classified as cash and cash equivalents, short-term investments and long-term investments on its condensed consolidated balance sheets, measured at fair value as of March 31, 2015 and December 31, 2014 (in thousands):
			Fair Value Measurements at March 31, 2015 Using
						Quoted Prices in		Significant
						Active Markets		Other		Significant
						for		Observable		Unobservable
						Identical Assets		Inputs		Inputs
	Description			Total		(Level 1)		(Level 2)		(Level 3)
	Cash & cash equivalents:
	Cash		$	48,174	$	48,174	$	-	$	-
	Money market funds			6,103		6,103		-		-
	Total		$	54,277	$	54,277	$	-	$	-
	Short-term investments:
	Corporate notes		$	6,169	$	-	$	6,169	$	-
	Total		$	6,169	$	-	$	6,169	$	-
	Long-term investments:
	Corporate notes		$	4,497	$	-	$	4,497	$	-
	Total		$	4,497	$	-	$	4,497	$	-
			Fair Value Measurements at December 31, 2014 Using
						Quoted Prices in		Significant
						Active Markets		Other		Significant
						for		Observable		Unobservable
						Identical Assets		Inputs		Inputs
	Description			Total		(Level 1)		(Level 2)		(Level 3)
	Cash & cash equivalents:
	Cash		$	34,452	$	34,452	$	-	$	-
	Money market funds			1,716		1,716		-		-
	Total		$	36,168	$	36,168	$	-	$	-
	Short-term investments:
	Corporate notes		$	19,241	$	-	$	19,241	$	-
	Commercial paper			800		-		800		-
	Total		$	20,041	$	-	$	20,041	$	-
	Long-term investments:
	U.S. government securities		$	1,000	$	1,000	$	-	$	-
	Corporate notes			4,495	$	-		4,495		-
	Total		$	5,495	$	1,000	$	4,495	$	-

Accounts_Receivable_And_Concen

Accounts Receivable And Concentration Of Credit Risk	3 Months Ended
	Mar. 31, 2015
Accounts Receivable And Concentration Of Credit Risk [Abstract]
Accounts Receivable And Concentration Of Credit Risk	5.ACCOUNTS RECEIVABLE AND CONCENTRATION OF CREDIT RISK
	The Company evaluates the creditworthiness of its customers and partners on a periodic basis and generally does not require collateral. The Company records unbilled accounts receivable, which represents amounts recognized as revenues for invoices that have not yet been sent to customers. This balance fluctuates depending on the contractual billing milestones and work performed related to projects specified in the contract. When the work performed is ahead of the billing milestones related to a services engagement, unbilled accounts receivable will be recorded. The balance of unbilled accounts receivable recorded as of March 31, 2015 and December 31, 2014 was $8.4 million and $8.0 million, respectively.
	No customer or partner accounted for more than 10% of the Company’s accounts receivable as of March 31, 2015 or December 31, 2014 or for more than 10% of the Company’s revenues for the three months ended March 31, 2015 or 2014. The Company’s top five partners collectively represented 14% and 17% of the Company’s accounts receivables balance at March 31, 2015 and December 31, 2014, respectively.

StockBased_Compensation

Stock-Based Compensation	3 Months Ended
	Mar. 31, 2015
Stock-Based Compensation [Abstract]
Stock-Based Compensation
	6	STOCK-BASED COMPENSATION
	Stock Option Plan
	The Company’s  2006 Equity Incentive Plan, as amended and as assumed by Interactive Intelligence Group, Inc. (the “2006 Plan”) authorizes the Board of Directors or the Compensation Committee, as applicable, to grant incentive and nonqualified stock options, stock appreciation rights, restricted stock, RSUs, performance shares, performance units and other stock-based awards. After adoption of the 2006 Plan by the Company’s shareholders in May 2006, the Company may no longer make any grants under previous plans. At the Company’s 2013 Annual Meeting of Shareholders held on May 22, 2013, the Company’s shareholders approved an amendment to the 2006 Plan which increased the number of shares available for issuance under the 2006 Plan by 2,000,000 shares. A maximum of 9,050,933 shares are available for delivery under the 2006 Plan. The number of shares available under the 2006 Plan is subject to adjustment for certain changes in the Company’s capital structure. The exercise price of options granted under the 2006 Plan is equal to the closing price of the Company’s common stock, as reported by The NASDAQ Global Select Market, on the business day immediately preceding the date of grant. As of March 31, 2015, there were 1,559,923 shares of stock available for issuance for equity compensation awards under the 2006 Plan.
	During 2014 and prior, the Company granted RSUs and three types of stock options. The first type of stock option was non-performance-based subject only to time-based vesting, and these stock options were granted by the Company as annual grants to executives, to certain new employees and to newly-elected non-employee directors.  These stock options vest in four equal annual installments beginning one year after the grant date.  The fair value of these option grants is determined on the date of grant and the related compensation expense is recognized for the entire award on a straight-line basis over the requisite service period.
	The second type of stock option granted by the Company was performance-based subject to cancellation if the specified performance targets are not met. If the applicable performance targets have been achieved, the options will vest in four equal annual installments beginning one year after the performance-related period has ended. The fair value of these stock option grants is determined on the date of grant and the related compensation expense is recognized over the related service period, including the initial period for which the specified performance targets must be met.
	The third type of stock option granted by the Company was director options granted to non-employee directors annually. These options were similar to the non-performance-based options described above except that the director options vest one year after the grant date. The fair value of these option grants is determined on the date of the grant and the related compensation expense is recognized over one year. These director options are generally granted at the Company’s Annual Meeting of Shareholders during the second quarter of each fiscal year.
	Beginning in 2015, the Company ceased granting stock options. The Company now only grants performance-based and non-performance based RSUs to directors, executives, certain key employees, and certain new employees, and the fair value of the RSUs is determined on the date of grant. Non-performance based RSUs vest in four equal annual installments beginning one year after the grant date. Performance-based RSUs vest in four equal annual installments once the individual has achieved the performance targets. RSUs are not included in issued and outstanding common stock until the shares are vested and settlement has occurred.
	The plans may be terminated by the Company’s Board of Directors at any time.
	Stock-Based Compensation Expense Information
	The following table summarizes the allocation of stock-based compensation expense related to employee and director stock options and RSUs under FASB ASC Topic 718, Compensation – Stock Compensation (“FASB ASC 718”) for the three months ended March 31, 2015 and 2014 (in thousands):
		Three Months Ended March 31,
		2015			2014
	Stock-based compensation expense by category:
	Costs of recurring revenues	$	454		$	307
	Costs of services revenues		129			106
	Sales and marketing		561			1,096
	Research and development		819			954
	General and administrative		1,030			777
	Total stock-based compensation expense	$	2,993		$	3,240
	Effect of stock-based compensation expense on net loss per share:
	Basic	$	-0.14		$	-0.16
	Diluted		-0.14			-0.16
	During the three months ended March 31, 2015, the Company capitalized $630,000 of stock-based compensation expense related to capitalized software. No stock-based compensation expenses were capitalized during the three months ended March 31, 2014.
	Stock Option and RSU Valuation
	The Company estimated the fair value of stock options using the Black-Scholes valuation model.
	There were no stock options granted during the first quarter of 2015. The weighted-average estimated per option value of non-performance-based and performance-based options granted under the 2006 Plan during the three months ended March 31, 2014 used the following assumptions:
		Three Months Ended
		March 31,
	Valuation assumptions for non-performance-based options:	2014
	Dividend yield	-	%
	Expected volatility	60.68	%
	Risk-free interest rate	1.28	%
	Expected life of option (in years)	4.25
		Three Months Ended
		March 31,
	Valuation assumptions for performance-based options:	2014
	Dividend yield	-	%
	Expected volatility	61.00	%
	Risk-free interest rate	1.39	%
	Expected life of option (in years)	4.50
	RSUs are valued using the fair market value of the Company’s stock on the date of grant and expense is recognized on a straight line basis taking into account an estimated forfeiture rate.
	Stock Option and RSU Activity
	The following table sets forth a summary of stock option activity for the three months ended March 31, 2015:
					Weighted-
					Average
					Exercise
			Options		Price
	Balances, beginning of year		1,350,799		$	32.95
	Options granted		-			-
	Options exercised		-81,076			18.42
	Options cancelled, forfeited or expired		-14,374			45.93
	Options outstanding		1,255,349			33.74
	Option price range	$	6.66 - 66.39
	Weighted-average fair value of options granted	$	-
	Options exercisable		875,293		$	28.51
	The following table sets forth information regarding the Company’s stock options outstanding and exercisable as of March 31, 2015:
							Options Outstanding				Options Exercisable
								Weighted-
								Average	Weighted-			Weighted-
								Remaining	Average			Average
	Range of Exercise							Contractual	Exercise			Exercise
	Prices						Number	Life	Price		Number	Price
	$	6.66	-	$	18.90		75,162	0.85	$	12.69	75,162	$	12.69
	19.66	-		19.66		225,475	0.96		19.66	225,475		19.66
	19.77	-		22.92		5,000	2.34		22.13	3,750		21.87
	24.50	-		24.50		227,400	2.98		24.50	149,900		24.50
	25.00	-		30.92		77,750	3.03		26.96	57,250		26.49
	32.33	-		32.33		182,250	1.99		32.33	176,625		32.33
	32.53	-		37.76		62,250	2.67		33.36	45,250		33.11
	39.97	-		39.97		149,062	4.07		39.97	63,128		39.97
	48.12	-		66.21		87,000	4.64		50.30	41,750		50.49
	66.39	-		66.39		164,000	4.94		66.39	37,003		66.39
Total shares/average price						1,255,349	2.83	$	33.74	875,293	$	28.51
The total intrinsic value of options exercised during the quarter ended ended March 31, 2015 was $2.0 million. The aggregate intrinsic value of options outstanding as of March 31, 2015 was $14.3 million and the aggregate intrinsic value of options currently exercisable as of March 31, 2015 was $12.4 million. The aggregate intrinsic value represents the total intrinsic value, based on the Company’s closing stock price per share of $41.18 as of March 31, 2015, which would have been realized by the option holders had all option holders exercised their options as of that date. The total number of in-the-money options exercisable as of March 31, 2015 represented approximately 796,540 shares with a weighted average exercise price of $25.60.
As of March 31, 2015, there was $7.1 million of total unrecognized compensation expense related to non-vested stock options. This expense is expected to be recognized over the weighted average remaining vesting period of 1.75 years.
The following table sets forth a summary of RSU activity for the three months ended March 31, 2015:
			Weighted-
			Average Grant
	Awards		Date Price
Balances, beginning of year	592,364		$	50.24
RSUs granted	380,087			43.37
RSUs vested	-158,283			45.62
RSUs forfeited	-13,520			55.68
RSUs outstanding	800,648			47.80
As of March 31, 2015, there was $36.1 million of total unrecognized compensation expense related to non-vested RSUs. This expense is expected to be recognized over the weighted average remaining vesting period of 2.78 years.

Income_Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2015
Income Taxes [Abstract]
Income Taxes
	7	INCOME TAXES
	The Company’s effective tax rate for the three months ended March 31, 2015 was (4.7%) without the effects of a discrete item, compared to 43.4% for the same period in 2014.  During the three months ended March 31, 2015, the Company recorded a net credit to income taxes of $1.9 million to correct an error in the Company’s valuation reserve for deferred tax assets.  The error is not considered material to the current or previously reported results.  With the effects of this discrete item, the Company’s effective tax rate was 28.3%.  The Company’s effective tax rate for the three months ended March 31, 2015 was lower than the federal statutory tax rate of 35.0% primarily due to the allocation of book operating results between the US and foreign entities and the impact of permanent tax differences on pre-tax operating results for the quarter.

Commitments_And_Contingencies

Commitments And Contingencies	3 Months Ended
	Mar. 31, 2015
Commitments And Contingencies [Abstract]
Commitments And Contingencies	8.COMMITMENTS AND CONTINGENCIES
	Legal Proceedings
	From time to time, the Company has received notification from competitors and other technology providers claiming that the Company’s technology infringes upon their proprietary rights. The Company cannot assure you that these matters can be resolved amicably without litigation, or that the Company will be able to enter into licensing arrangements on terms and conditions that would not have a material adverse effect on its business, financial condition or results of operations.
	From time to time, the Company is also involved in certain legal proceedings in the ordinary course of conducting its business. While the ultimate liability pursuant to these actions cannot currently be determined, the Company believes these legal proceedings will not have a material adverse effect on its financial position or results of operations. Litigation, in general, and intellectual property litigation, in particular, can be expensive and disruptive to normal business operations. Moreover, the results of complex legal proceedings are difficult to predict.
	Guarantees
	The Company provides indemnifications of varying scope and amount to certain customers against claims of intellectual property infringement made by third parties arising from the use of its solutions. The Company’s direct software license agreements include certain provisions for indemnifying customers, in material compliance with their license agreement, against liabilities if the Company’s software products infringe upon a third party's intellectual property rights, over the life of the agreement. There is no maximum potential amount of future payments set under the guarantee. However, the Company may at any time and at its option and expense:  (i) procure the right of the customer to continue to use the Company’s software that may infringe a third party’s rights; (ii) modify its software so as to avoid infringement; or (iii) require the customer to return its software and refund the customer the fee actually paid by the customer for its software less depreciation based on a five-year straight-line depreciation schedule. The customer’s failure to provide timely notice or reasonable assistance will relieve the Company of its obligations under this indemnification to the extent that it has been actually and materially prejudiced by such failure. To date, the Company has not incurred, nor does it expect to incur, any material related costs and, therefore, has not reserved for such liabilities, in accordance with FASB ASC Topic 460, Guarantees.
	The Company’s software license agreements also include a warranty that its software products will substantially conform to its software user documentation for a period of one year, provided the customer is in material compliance with the software license agreement. To date, the Company has not incurred any material costs associated with these product warranties, and as such, has not reserved for any such warranty liabilities in its operating results.
	Lease Commitments
	The Company’s world headquarters are located in approximately 315,000 square feet of space in three office buildings in Indianapolis, Indiana. This space was formerly leased pursuant to that certain Office Lease Agreement (the “Office Lease”), dated April 1, 2001, between the Company and Duke Realty Limited Partnership (formerly Duke-Weeks Realty Limited Partnership), as amended.  On May 6, 2014, the Company entered into a lease termination agreement with Duke Realty Limited Partnership, whereby the Office Lease (and the eight amendments thereto) was terminated.  In place of such Office Lease and amendments, on May 6, 2014, the Company entered into new separate lease agreements with Duke Realty Limited Partnership for each of the three office buildings, one of which expires on March 31, 2018 and two of which expire on or after June 30, 2025.
	On May 6, 2014, the Company also entered into a lease agreement with Duke Construction Limited Partnership to expand its world headquarters to include a fourth, build-to-suit office building in Indianapolis, Indiana.  The target date for completion of construction of the fourth office building is mid-2015 and the lease term expires 10 years after construction is completed.
	The following amounts set forth in the table are as of March 31, 2015 (in thousands):
		Payments Due by Period
				Less than						More than
		Total		1 Year		1-3 Years		3-5 Years		5 Years
	Contractual Obligations
	Operating lease obligations	$	101,343	$	10,478	$	26,373	$	18,873	$	45,619
	Purchase obligations		17,027		5,635		9,142		2,250		-
	Other obligations		1,702		-		-		1,702		-
	Total	$	120,072	$	16,113	$	35,515	$	22,825	$	45,619
	As set forth in the Contractual Obligations table, the Company has operating lease obligations and purchase obligations that are not recorded in its consolidated financial statements. The operating lease obligations represent future payments on leases classified as operating leases and disclosed pursuant to FASB ASC Topic 840, Leases (“FASB ASC 840”). The obligations include the operating leases of the Company’s world headquarters, some of which extend to the year 2025, and the leases of several other locations for its offices in the United States and 20 other countries with initial lease terms of up to five years. The Company rents office space for sales, services, development and international offices under month-to-month leases. In accordance with FASB ASC 840, rental expense is recognized ratably over the lease period, including those leases containing escalation clauses.
	Other Contingencies
	The Company has received and may continue to receive certain payroll tax credits and real estate tax abatements that were granted to the Company based upon specified growth projections.  If the Company’s actual performance is less than those projections, the Company may be subject to repayment of some or all of the tax credits or payment of additional real estate taxes in the case of the abatements.  The Company does not believe that it will be subject to payment of any money related to these taxes; however, the Company cannot provide assurance as to the outcome.

Acquisitions

Acquisitions	3 Months Ended
	Mar. 31, 2015
Acquisitions [Abstract]
Acquisitions
	9	ACQUISITIONS
	OrgSpan Acquisition
	On May 14, 2014, the Company entered into a stock purchase agreement and acquired OrgSpan, Inc. (“OrgSpan”), a privately held provider of cloud-based enterprise social communications solutions.  The Company purchased OrgSpan to leverage technology that will provide efficient deployment of the Company’s PureCloud Platform. As previously disclosed, Donald E. Brown, the Company’s Chairman of the Board, President and Chief Executive Officer, was a founder and majority stockholder of OrgSpan.  The Company purchased OrgSpan for approximately $14.1 million, partially funded with cash on hand, which included the repayment of OrgSpan’s outstanding debt of approximately $8.0 million. OrgSpan’s outstanding debt consisted primarily of operating loans provided by Dr. Brown bearing interest at a rate of 4.25% per annum. Approximately $1.4 million in cash was paid to OrgSpan’s stockholders (other than Dr. Brown) and to holders of vested OrgSpan stock options. In exchange for his shares of OrgSpan stock, Dr. Brown has the right to receive an aggregate of 98,999 restricted shares of the Company’s common stock (the “Restricted Shares”), representing approximately $4.7 million of the purchase price, which Restricted Shares will vest and be issued by the Company upon the achievement of certain performance-based conditions tied to the launch and sales of the Company’s PureCloud Platform, which incorporates certain OrgSpan products and technology. The Restricted Shares will be unregistered. The difference between the $15.6 million purchase price previously disclosed in the Form 8-K filed on May 14, 2014 and the $14.1 million noted above is a result of the difference in the value of the 98,999 Restricted Shares received by Dr. Brown for accounting purposes. The Company also retained 38 OrgSpan employees as part of the transaction.
	The acquisition was accounted for using the acquisition method of accounting in accordance with FASB ASC Topic 805, Business Combinations (“FASB ASC 805”). The results of OrgSpan’s operations were included in the Company’s condensed consolidated financial statements commencing on the acquisition date.
	The purchase price allocations for the OrgSpan transaction were prepared by the Company’s management utilizing a third-party valuation report, which was prepared in accordance with the provisions of FASB ASC 805, and other tools available to the Company, including conversations with OrgSpan’s management and historical data from the Company’s other acquisitions. The following table summarizes the fair value of the intangible and other assets acquired and liabilities assumed at the date of the acquisition (in thousands):
			1-May-14
	Cash and cash equivalents		$	61
	Prepaid expenses			54
	Property and equipment, net			144
	Intangible assets, net			5,766
	Goodwill			8,202
	Total assets acquired			14,227
	Accrued accounts payable			-5
	Other current liabilities			-44
	Other long-term liabilities			-128
	Net assets acquired		$	14,050
	Professional fees related to this acquisition and recognized as of March 31, 2015 totaled $613,000, and included transaction costs such as legal, accounting, and valuation services, which were expensed as incurred. These costs are included within general and administrative expenses on the condensed consolidated statements of operations.
	The premium paid over the fair value of the net assets acquired in the purchase, or goodwill, was primarily attributed to OrgSpan’s existing trained workforce. The goodwill is expected to be deductible for tax purposes, as the Company made a Section 338(h)(10) election for this acquisition.
	Intangible assets acquired resulting from this acquisition consisted of technology, which is amortized on a straight-line basis. The following sets forth the current net book value of technology acquired and its original economic useful life (dollars in thousands):
			As of March 31, 2015
									Economic
					Accumulated				Useful Life
			Gross Amount		Amortization		Net Amount		(in years)
	Technology		$	5,766	$	529	$	5,237	10
	Pro Forma Results
	The Company has not furnished pro forma financial information related to its acquisition of OrgSpan because such information is not material individually or in the aggregate to the overall financial results of the Company.

Derivatives

Derivatives	3 Months Ended
	Mar. 31, 2015
Derivatives [Abstract]
Derivatives	10.DERIVATIVES
	The Company enters into derivative contracts to mitigate its foreign currency risk associated with transacting business internationally.  The Company uses foreign currency forward contracts to hedge the revaluation exposure of its net monetary assets and liabilities including cash, accounts receivable, accounts payable and certain intercompany payables and receivables.  These hedges are not designated under GAAP, and all realized and unrealized gains and losses are recorded as incurred within other income (expense) on the Company’s condensed consolidated statements of operations.  The objective is to offset the gains and losses on the underlying exposures with the gains and losses from the forward contracts.  The Company’s hedging policy prohibits entering into hedge contracts that are speculative in nature.
	The Company records the fair value of its outstanding hedge contracts in other current assets and accrued liabilities depending upon the market value of the forward contracts at each balance sheet date.  The following table summarizes the notional amount and fair value of the Company’s outstanding currency contracts at March 31, 2015 and December 31, 2014, respectively (in thousands).
			USD Equivalent Notional Amount
			31-Mar-15		31-Dec-14
	Euro		$	3,034	$	3,041
	US Dollar			1,410		600
	Japanese Yen			499		-
	Swedish Krona			204		249
	Australian Dollar			-		738
	Total		$	5,147	$	4,628
			Fair Value USD (1)
			31-Mar-15		31-Dec-14
	Derivative Asset		$	25	$	17
	___________
		-1		The fair value measurement of these derivative contracts falls within Level 2 of the fair value hierarchy as defined in FASB ASC 820. See Note 4 - Investments for further information.
	During the three months ended March 31, 2015, the Company recorded hedging gains of $491,000 compared to hedging losses of $179,000 for the same period last year.

Net_Income_Loss_Per_Share_Tabl

Net Income (Loss) Per Share (Tables)	3 Months Ended
	Mar. 31, 2015
Net Income (Loss) Per Share [Abstract]
Calculation Of Basic And Diluted Net Income Per Share
		Three Months Ended March 31,
		2015		2014
	Net loss, as reported (A)	$	-3,459	$	-2,564
	Weighted average shares of common stock outstanding (B)		21,447		20,689
	Dilutive effect of employee stock options and RSUs		-		-
	Common stock and common stock equivalents (C)		21,447		20,689
	Net loss per share:
	Basic (A/B)	$	-0.16	$	-0.12
	Diluted (A/C)		-0.16		-0.12

Investments_Tables

Investments (Tables)	3 Months Ended
	Mar. 31, 2015
Investments [Abstract]
Financial Assets Measured At Fair Value
		Fair Value Measurements at March 31, 2015 Using
					Quoted Prices in		Significant
					Active Markets		Other		Significant
					for		Observable		Unobservable
					Identical Assets		Inputs		Inputs
	Description		Total		(Level 1)		(Level 2)		(Level 3)
	Cash & cash equivalents:
	Cash	$	48,174	$	48,174	$	-	$	-
	Money market funds		6,103		6,103		-		-
	Total	$	54,277	$	54,277	$	-	$	-
	Short-term investments:
	Corporate notes	$	6,169	$	-	$	6,169	$	-
	Total	$	6,169	$	-	$	6,169	$	-
	Long-term investments:
	Corporate notes	$	4,497	$	-	$	4,497	$	-
	Total	$	4,497	$	-	$	4,497	$	-
		Fair Value Measurements at December 31, 2014 Using
					Quoted Prices in		Significant
					Active Markets		Other		Significant
					for		Observable		Unobservable
					Identical Assets		Inputs		Inputs
	Description		Total		(Level 1)		(Level 2)		(Level 3)
	Cash & cash equivalents:
	Cash	$	34,452	$	34,452	$	-	$	-
	Money market funds		1,716		1,716		-		-
	Total	$	36,168	$	36,168	$	-	$	-
	Short-term investments:
	Corporate notes	$	19,241	$	-	$	19,241	$	-
	Commercial paper		800		-		800		-
	Total	$	20,041	$	-	$	20,041	$	-
	Long-term investments:
	U.S. government securities	$	1,000	$	1,000	$	-	$	-
	Corporate notes		4,495	$	-		4,495		-
	Total	$	5,495	$	1,000	$	4,495	$	-

StockBased_Compensation_Tables

Stock-Based Compensation (Tables)	3 Months Ended
	Mar. 31, 2015
Stock-Based Compensation [Abstract]
Allocation of Stock-Based Compensation Expense
		Three Months Ended March 31,
		2015			2014
	Stock-based compensation expense by category:
	Costs of recurring revenues	$	454		$	307
	Costs of services revenues		129			106
	Sales and marketing		561			1,096
	Research and development		819			954
	General and administrative		1,030			777
	Total stock-based compensation expense	$	2,993		$	3,240
	Effect of stock-based compensation expense on net loss per share:
	Basic	$	-0.14		$	-0.16
	Diluted		-0.14			-0.16
Schedule of Valuation Assumptions
		Three Months Ended
		March 31,
	Valuation assumptions for non-performance-based options:	2014
	Dividend yield	-	%
	Expected volatility	60.68	%
	Risk-free interest rate	1.28	%
	Expected life of option (in years)	4.25
		Three Months Ended
		March 31,
	Valuation assumptions for performance-based options:	2014
	Dividend yield	-	%
	Expected volatility	61.00	%
	Risk-free interest rate	1.39	%
	Expected life of option (in years)	4.50
Summary of Stock Option Activity
					Weighted-
					Average
					Exercise
			Options		Price
	Balances, beginning of year		1,350,799		$	32.95
	Options granted		-			-
	Options exercised		-81,076			18.42
	Options cancelled, forfeited or expired		-14,374			45.93
	Options outstanding		1,255,349			33.74
	Option price range	$	6.66 - 66.39
	Weighted-average fair value of options granted	$	-
	Options exercisable		875,293		$	28.51
Summary of Stock Options Outstanding and Exercisable
							Options Outstanding				Options Exercisable
								Weighted-
								Average	Weighted-			Weighted-
								Remaining	Average			Average
	Range of Exercise							Contractual	Exercise			Exercise
	Prices						Number	Life	Price		Number	Price
	$	6.66	-	$	18.90		75,162	0.85	$	12.69	75,162	$	12.69
		19.66	-		19.66		225,475	0.96		19.66	225,475		19.66
		19.77	-		22.92		5,000	2.34		22.13	3,750		21.87
		24.50	-		24.50		227,400	2.98		24.50	149,900		24.50
		25.00	-		30.92		77,750	3.03		26.96	57,250		26.49
		32.33	-		32.33		182,250	1.99		32.33	176,625		32.33
		32.53	-		37.76		62,250	2.67		33.36	45,250		33.11
		39.97	-		39.97		149,062	4.07		39.97	63,128		39.97
		48.12	-		66.21		87,000	4.64		50.30	41,750		50.49
		66.39	-		66.39		164,000	4.94		66.39	37,003		66.39
	Total shares/average price						1,255,349	2.83	$	33.74	875,293	$	28.51
Summary of RSU activity
				Weighted-
				Average Grant
		Awards		Date Price
	Balances, beginning of year	592,364		$	50.24
	RSUs granted	380,087			43.37
	RSUs vested	-158,283			45.62
	RSUs forfeited	-13,520			55.68
	RSUs outstanding	800,648			47.80

Commitments_And_Contingencies_

Commitments And Contingencies (Tables)	3 Months Ended
	Mar. 31, 2015
Commitments And Contingencies [Abstract]
Schedule Of Contractual Obligations
		Payments Due by Period
				Less than						More than
		Total		1 Year		1-3 Years		3-5 Years		5 Years
	Contractual Obligations
	Operating lease obligations	$	101,343	$	10,478	$	26,373	$	18,873	$	45,619
	Purchase obligations		17,027		5,635		9,142		2,250		-
	Other obligations		1,702		-		-		1,702		-
	Total	$	120,072	$	16,113	$	35,515	$	22,825	$	45,619

Acquisitions_Tables

Acquisitions (Tables)	3 Months Ended
	Mar. 31, 2015
Acquisitions [Abstract]
Fair Value Of The Intangible And Other Assets Acquired And Liabilities Assumed
		1-May-14
	Cash and cash equivalents	$	61
	Prepaid expenses		54
	Property and equipment, net		144
	Intangible assets, net		5,766
	Goodwill		8,202
	Total assets acquired		14,227
	Accrued accounts payable		-5
	Other current liabilities		-44
	Other long-term liabilities		-128
	Net assets acquired	$	14,050
Intangible Assets Acquired And Economic Useful Life
		As of March 31, 2015
								Economic
				Accumulated				Useful Life
		Gross Amount		Amortization		Net Amount		(in years)
	Technology	$	5,766	$	529	$	5,237	10

Derivatives_Tables

Derivatives (Tables)	3 Months Ended
	Mar. 31, 2015
Derivatives [Abstract]
Schedule Of Derivative Notional Amount And Fair Value
			USD Equivalent Notional Amount
			31-Mar-15		31-Dec-14
	Euro		$	3,034	$	3,041
	US Dollar			1,410		600
	Japanese Yen			499		-
	Swedish Krona			204		249
	Australian Dollar			-		738
	Total		$	5,147	$	4,628
			Fair Value USD (1)
			31-Mar-15		31-Dec-14
	Derivative Asset		$	25	$	17
	___________
		-1		The fair value measurement of these derivative contracts falls within Level 2 of the fair value hierarchy as defined in FASB ASC 820. See Note 4 - Investments for further information.

Financial_Statement_Presentati1

Financial Statement Presentation (Narrative) (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014
Financial Statement Presentation [Abstract]
Prior Period Reclassification Adjustment	$700

Recovered_Sheet1

Summary of Certain Accounting Policies and Recent Accounting Pronouncements (Narrative) (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Summary Of Certain Accounting Policies And Recent Accounting Pronouncements [Abstract]
Internal use software expenses	$5.60	$1.80
Capitalized costs with development and implementation of business systems	$0.90	$0.60

Net_Income_Loss_Per_Share_Deta

Net Income (Loss) Per Share (Details) (USD $)	3 Months Ended
In Thousands, except Share data, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Net Income (Loss) Per Share [Abstract]
Net income (loss), as reported (A)	($3,459)	($2,564)
Weighted average shares of common stock outstanding (B)	21,447	20,689
Common stock and common stock equivalents (C)	21,447	20,689
Basic (A/B)	($0.16)	($0.12)
Diluted (A/C)	($0.16)	($0.12)
Stock options excluded from diluted net income (loss) per share	374,000	214,000

Investments_Financial_Assets_M

Investments (Financial Assets Measured At Fair Value) (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash & cash equivalents, Total	$54,277	$36,168
Short-Term Investments [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Maturity period	1 year
Investments, Total	6,169	20,041
Long-Term Investments [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Maturity period	3 years
Investments, Total	4,497	5,495
Quoted Prices in Active Markets for Identical Assets, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash & cash equivalents, Total	54,277	36,168
Quoted Prices in Active Markets for Identical Assets, Level 1 [Member] | Short-Term Investments [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Total
Quoted Prices in Active Markets for Identical Assets, Level 1 [Member] | Long-Term Investments [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Total		1,000
Significant Other Observable Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash & cash equivalents, Total
Significant Other Observable Inputs, Level 2 [Member] | Short-Term Investments [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Total	6,169	20,041
Significant Other Observable Inputs, Level 2 [Member] | Long-Term Investments [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Total	4,497	4,495
Significant Unobservable Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash & cash equivalents, Total
Significant Unobservable Inputs, Level 3 [Member] | Short-Term Investments [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Total
Significant Unobservable Inputs, Level 3 [Member] | Long-Term Investments [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Total
Cash [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash & cash equivalents, Total	48,174	34,452
Cash [Member] | Quoted Prices in Active Markets for Identical Assets, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash & cash equivalents, Total	48,174	34,452
Cash [Member] | Significant Other Observable Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash & cash equivalents, Total
Cash [Member] | Significant Unobservable Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash & cash equivalents, Total
Money Market Funds [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash & cash equivalents, Total	6,103	1,716
Money Market Funds [Member] | Quoted Prices in Active Markets for Identical Assets, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash & cash equivalents, Total	6,103	1,716
Money Market Funds [Member] | Significant Other Observable Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash & cash equivalents, Total
Money Market Funds [Member] | Significant Unobservable Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash & cash equivalents, Total
Corporate Notes [Member] | Short-Term Investments [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Total	6,169	19,241
Corporate Notes [Member] | Long-Term Investments [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Total	4,497	4,495
Corporate Notes [Member] | Quoted Prices in Active Markets for Identical Assets, Level 1 [Member] | Short-Term Investments [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Total
Corporate Notes [Member] | Quoted Prices in Active Markets for Identical Assets, Level 1 [Member] | Long-Term Investments [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Total
Corporate Notes [Member] | Significant Other Observable Inputs, Level 2 [Member] | Short-Term Investments [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Total	6,169	19,241
Corporate Notes [Member] | Significant Other Observable Inputs, Level 2 [Member] | Long-Term Investments [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Total	4,497	4,495
Corporate Notes [Member] | Significant Unobservable Inputs, Level 3 [Member] | Short-Term Investments [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Total
Corporate Notes [Member] | Significant Unobservable Inputs, Level 3 [Member] | Long-Term Investments [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Total
Commercial Paper [Member] | Short-Term Investments [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Total		800
Commercial Paper [Member] | Significant Other Observable Inputs, Level 2 [Member] | Short-Term Investments [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Total		800
US Government Securities [Member] | Long-Term Investments [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Total		1,000
US Government Securities [Member] | Quoted Prices in Active Markets for Identical Assets, Level 1 [Member] | Long-Term Investments [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Total		$1,000

Accounts_Receivable_And_Concen1

Accounts Receivable And Concentration Of Credit Risk (Details) (USD $)	3 Months Ended		12 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014
	customer	customer	customer
Concentration Risk [Line Items]
Unbilled accounts receivable	8.4		8
Revenue [Member] | Customer Concentration Risk [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	10.00%	10.00%
Number of customers or partners with significant holding	0	0
Accounts Receivable [Member] | Customer Concentration Risk [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	10.00%		10.00%
Number of customers or partners with significant holding	0		0
Accounts Receivable [Member] | Top Five Partners [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	14.00%		17.00%
Number of customers or partners with significant holding	5		5

StockBased_Compensation_Narrat

Stock-Based Compensation (Narrative) (Details) (USD $)	3 Months Ended	12 Months Ended	0 Months Ended
	Mar. 31, 2015	Dec. 31, 2014	22-May-13	Mar. 31, 2014
		item
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total intrinsic value of options exercised	$2,000,000
Capitalized Computer Software, Net	630,000			0
Aggregate intrinsic value of options outstanding	14,300,000
Aggregate intrinsic value of options currently exercisable	12,400,000
Company's closing stock price per share	$41.18
Total unrecognized compensation cost related to non-vested stock options	7,100,000
Weighted average remaining vesting period	1 year 9 months
Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding stock options	1,255,349	1,350,799
Total number of in-the-money options exercisable	875,293
Weighted average exercise price	$28.51
In the Money Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total number of in-the-money options exercisable	796,540
Weighted average exercise price	$25.60
Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding stock options	800,648	592,364
Weighted average remaining vesting period	2 years 9 months 11 days
Total unrecognized compensation cost related to non-vested RSUs	$36,100,000
Performance-Based Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of equal annual installments		4
Award vesting period		1 year
Non-Performance-Based Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of equal annual installments		4
Award vesting period		1 year
Director Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period		1 year
Period of recognizing compensation expense		1 year
Performance Based Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of equal annual installments	4
Non Performance Based Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of equal annual installments	4
Award vesting period	1 year
2006 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Additional shares available for issuance			2,000,000
Shares available for delivery	9,050,933
Shares of stock available for issuance for equity compensation awards	1,559,923

StockBased_Compensation_Alloca

Stock-Based Compensation (Allocation of Stock-Based Compensation Expense) (Details) (USD $)	3 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total stock-based compensation expense	$2,993	$3,240
Effects of Stock-based compensation: Basic	($0.14)	($0.16)
Effects of Stock-based compensation: Diluted	($0.14)	($0.16)
Costs Of Recurring Revenues [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total stock-based compensation expense	454	307
Costs of Services Revenues [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total stock-based compensation expense	129	106
Sales and Marketing [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total stock-based compensation expense	561	1,096
Research and Development [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total stock-based compensation expense	819	954
General and Administrative [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total stock-based compensation expense	$1,030	$777

StockBased_Compensation_Schedu

Stock-Based Compensation (Schedule of Valuation Assumptions) (Details)	3 Months Ended
	Mar. 31, 2014
Non-Performance-Based Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility	60.68%
Risk-free interest rate	1.28%
Expected life of option (in years)	4 years 3 months
Performance-Based Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility	61.00%
Risk-free interest rate	1.39%
Expected life of option (in years)	4 years 6 months

StockBased_Compensation_Summar

Stock-Based Compensation (Summary of Stock Option Activity) (Details) (Stock Options [Member], USD $)	3 Months Ended
	Mar. 31, 2015
Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Balances, beginning of year	1,350,799
Exercised	-81,076
Cancelled, forfeited or expired	-14,374
Options outstanding at end of year	1,255,349
Range of exercise price, lower limit	$6.66
Range of exercise price, upper limit	$66.39
Options exercisable at end of year	875,293
Weighted-Average Exercise Price, Balance, beginning of year	$32.95
Weighted-Average Exercise Price, Exercised	$18.42
Weighted-Average Exercise Price, Cancelled, forfeited or expired	$45.93
Weighted-Average Exercise Price, Options Outstanding at end of year	$33.74
Weighted-Average Exercise Price, Options exercisable at end of year	$28.51

StockBased_Compensation_Summar1

Stock-Based Compensation (Summary of Stock Options Outstanding and Exercisable) (Details) (USD $)	3 Months Ended
	Mar. 31, 2015
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options outstanding, number	1,255,349
Options outstanding, weighted-average remaining contractual life	2 years 9 months 29 days
Options outstanding, weighted-average exercise price	$33.74
Options exercisable, number	875,293
Options exercisable, weighted-average exercise price	$28.51
Range 1 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of exercise price, lower limit	$6.66
Range of exercise price, upper limit	$18.90
Options outstanding, number	75,162
Options outstanding, weighted-average remaining contractual life	10 months 6 days
Options outstanding, weighted-average exercise price	$12.69
Options exercisable, number	75,162
Options exercisable, weighted-average exercise price	$12.69
Range 2 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of exercise price, lower limit	$19.66
Range of exercise price, upper limit	$19.66
Options outstanding, number	225,475
Options outstanding, weighted-average remaining contractual life	11 months 16 days
Options outstanding, weighted-average exercise price	$19.66
Options exercisable, number	225,475
Options exercisable, weighted-average exercise price	$19.66
Range 3 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of exercise price, lower limit	$19.77
Range of exercise price, upper limit	$22.92
Options outstanding, number	5,000
Options outstanding, weighted-average remaining contractual life	2 years 4 months 2 days
Options outstanding, weighted-average exercise price	$22.13
Options exercisable, number	3,750
Options exercisable, weighted-average exercise price	$21.87
Range 4 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of exercise price, lower limit	$24.50
Range of exercise price, upper limit	$24.50
Options outstanding, number	227,400
Options outstanding, weighted-average remaining contractual life	2 years 11 months 23 days
Options outstanding, weighted-average exercise price	$24.50
Options exercisable, number	149,900
Options exercisable, weighted-average exercise price	$24.50
Range 5 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of exercise price, lower limit	$25
Range of exercise price, upper limit	$30.92
Options outstanding, number	77,750
Options outstanding, weighted-average remaining contractual life	3 years 11 days
Options outstanding, weighted-average exercise price	$26.96
Options exercisable, number	57,250
Options exercisable, weighted-average exercise price	$26.49
Range 6 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of exercise price, lower limit	$32.33
Range of exercise price, upper limit	$32.33
Options outstanding, number	182,250
Options outstanding, weighted-average remaining contractual life	1 year 11 months 27 days
Options outstanding, weighted-average exercise price	$32.33
Options exercisable, number	176,625
Options exercisable, weighted-average exercise price	$32.33
Range 7 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of exercise price, lower limit	$32.53
Range of exercise price, upper limit	$37.76
Options outstanding, number	62,250
Options outstanding, weighted-average remaining contractual life	2 years 8 months 1 day
Options outstanding, weighted-average exercise price	$33.36
Options exercisable, number	45,250
Options exercisable, weighted-average exercise price	$33.11
Range 8 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of exercise price, lower limit	$39.97
Range of exercise price, upper limit	$39.97
Options outstanding, number	149,062
Options outstanding, weighted-average remaining contractual life	4 years 26 days
Options outstanding, weighted-average exercise price	$39.97
Options exercisable, number	63,128
Options exercisable, weighted-average exercise price	$39.97
Range 9 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of exercise price, lower limit	$48.12
Range of exercise price, upper limit	$66.21
Options outstanding, number	87,000
Options outstanding, weighted-average remaining contractual life	4 years 7 months 21 days
Options outstanding, weighted-average exercise price	$50.30
Options exercisable, number	41,750
Options exercisable, weighted-average exercise price	$50.49
Range 10 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of exercise price, lower limit	$66.39
Range of exercise price, upper limit	$66.39
Options outstanding, number	164,000
Options outstanding, weighted-average remaining contractual life	4 years 11 months 9 days
Options outstanding, weighted-average exercise price	$66.39
Options exercisable, number	37,003
Options exercisable, weighted-average exercise price	$66.39

StockBased_Compensation_Summar2

Stock-Based Compensation (Summary of RSU Activity) (Details) (Restricted Stock Units (RSUs) [Member], USD $)	3 Months Ended
	Mar. 31, 2015
Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Balances, beginning of year	592,364
Granted	380,087
Vested	-158,283
Forfeited	-13,520
Options outstanding at end of year	800,648
Weighted-Average Exercise Price, Balance, beginning of year	$50.24
Weighted-Average Exercise Price, Granted	$43.37
Weighted-Average Exercise Price, Vested	$45.62
Weighted-Average Exercise Price, Forfeited	$55.68
Weighted-Average Exercise Price, Options Outstanding at end of year	$47.80

Income_Taxes_Narrative_Details

Income Taxes (Narrative) (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Income Taxes [Abstract]
Effective income tax rate	28.30%
Effective tax rate without the effect of discrete item	4.70%	43.40%
Discrete items	$1.90
Federal statutory tax rate	35.00%

Commitments_And_Contingencies_1

Commitments And Contingencies (Narrative) (Details)	3 Months Ended
	Mar. 31, 2015
	item
	sqft
	country
Operating Leased Assets [Line Items]
Amortization period	5 years
Warranty period	1 year
Size Of Building	315,000
Number Of Office Buildings	3
Number on countries in which there are leases	20
Headquarters [Member]
Operating Leased Assets [Line Items]
Lease term	10 years
International Locations [Member]
Operating Leased Assets [Line Items]
Lease term	5 years

Commitments_And_Contingencies_2

Commitments And Contingencies (Schedule Of Contractual Obligations) (Details) (USD $)	Mar. 31, 2015
In Thousands, unless otherwise specified
Commitments And Contingencies [Abstract]
Operating lease obligations	$101,343
Operating lease obligations, Less than 1 Year	10,478
Operating lease obligations, 1-3 Years	26,373
Operating lease obligations, 3-5 Years	18,873
Operating lease obligations, More than 5 Years	45,619
Purchase obligations	17,027
Purchase obligations, Less than 1 Year	5,635
Purchase obligations, 1-3 Years	9,142
Purchase obligations, 3-5 Years	2,250
Other obligations	1,702
Other obligations, 3-5 Years	1,702
Contractual Obligations	120,072
Contractual Obligations, Less than 1 Year	16,113
Contractual Obligations, 1-3 Years	35,515
Contractual Obligations, 3-5 Years	22,825
Contractual Obligations, More than 5 Years	$45,619

Acquisitions_Narrative_Details

Acquisitions (Narrative) (Details) (USD $)	0 Months Ended	3 Months Ended
	14-May-14	Mar. 31, 2015	14-May-14
		employee
Business Acquisition [Line Items]
Amortization period of intangible assets		5 years
OrgSpan, Inc. [Member]
Business Acquisition [Line Items]
Consideration transferred	$14,100,000
Outstanding debt	8,000,000		8,000,000
Interest rate	4.25%		4.25%
Cash paid for acquisition	1,400,000
Shares exchanged for acquisition	98,999		98,999
Shares exchanged for acquisition, value		4,700,000
Preliminary purchase price	15,600,000		15,600,000
Recognized professional fees		$613,000
Assembled workforce, number of employees		38

Acquisitions_Fair_Value_Of_The

Acquisitions (Fair Value Of The Intangible And Other Assets Acquired And Liabilities Assumed) (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014	1-May-14
In Thousands, unless otherwise specified
Business Acquisition [Line Items]
Goodwill	$42,429	$43,732
OrgSpan, Inc. [Member]
Business Acquisition [Line Items]
Cash and cash equivalents			61
Prepaid expenses			54
Property and equipment, net			144
Intangible assets, net			5,766
Goodwill			8,202
Total assets acquired			14,227
Accrued accounts payable			-5
Other current liabilities			-44
Other long-term liabilities			-128
Net assets acquired			$14,050

Acquisitions_Intangible_Assets

Acquisitions (Intangible Assets Acquired And Economic Useful Life) (Details) (Technology [Member], USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015
Technology [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Gross Amount	$5,766
Accumulated Amortization	529
Net Amount	$5,237
Economic Useful Life (in years)	10 years

Derivatives_Narrative_Details

Derivatives (Narrative) (Details) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Derivatives [Abstract]
Hedging gains (losses)	$491,000	($179,000)

Derivatives_Schedule_Of_Deriva

Derivatives (Schedule Of Derivative Notional Amount And Fair Value) (Details) (USD $)	Mar. 31, 2015		Dec. 31, 2014
In Thousands, unless otherwise specified
Derivatives, Fair Value [Line Items]
Notional Amount	$5,147		$4,628
Derivative Asset / (Liability)	25	[1]	17	[1]
Euro [Member]
Derivatives, Fair Value [Line Items]
Notional Amount	3,034		3,041
US Dollar [Member]
Derivatives, Fair Value [Line Items]
Notional Amount	1,410		600
Japanese Yen [Member]
Derivatives, Fair Value [Line Items]
Notional Amount	499
Swedish Krona [Member]
Derivatives, Fair Value [Line Items]
Notional Amount	204		249
Australia Dollar [Member]
Derivatives, Fair Value [Line Items]
Notional Amount			$738
[1]	The fair value measurement of these derivative contracts falls within Level 2 of the fair value hierarchy as defined in FASB ASC 820. See Note 4 - Investments for further information